160 related articles for article (PubMed ID: 24270471)
1. Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune system.
Dieli F; Fadda R; Caccamo N
Cell Mol Immunol; 2014 Mar; 11(2):123-5. PubMed ID: 24270471
[No Abstract] [Full Text] [Related]
2. A fat story-antigen presentation by butyrophilin 3A1 to γδ T cells.
Esser C
Cell Mol Immunol; 2014 Jan; 11(1):5-7. PubMed ID: 24097036
[No Abstract] [Full Text] [Related]
3. Critical role of butyrophilin 3A1 in presenting prenyl pyrophosphate antigens to human γδ T cells.
Kabelitz D
Cell Mol Immunol; 2014 Mar; 11(2):117-9. PubMed ID: 24097034
[No Abstract] [Full Text] [Related]
4. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells.
Vavassori S; Kumar A; Wan GS; Ramanjaneyulu GS; Cavallari M; El Daker S; Beddoe T; Theodossis A; Williams NK; Gostick E; Price DA; Soudamini DU; Voon KK; Olivo M; Rossjohn J; Mori L; De Libero G
Nat Immunol; 2013 Sep; 14(9):908-16. PubMed ID: 23872678
[TBL] [Abstract][Full Text] [Related]
5. Resolving the mystery of pyrophosphate antigen presentation.
Willcox CR; Mohammed F; Willcox BE
Nat Immunol; 2013 Sep; 14(9):886-7. PubMed ID: 23959177
[No Abstract] [Full Text] [Related]
6. Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytes.
Decaup E; Duault C; Bezombes C; Poupot M; Savina A; Olive D; Fournié JJ
Immunol Lett; 2014 Sep; 161(1):133-7. PubMed ID: 24925024
[TBL] [Abstract][Full Text] [Related]
7. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.
Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y
Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human γδ T cell proliferation and effector functions by neutrophil serine proteases.
Fazio J; Kalyan S; Wesch D; Kabelitz D
Scand J Immunol; 2014 Dec; 80(6):381-9. PubMed ID: 25345993
[TBL] [Abstract][Full Text] [Related]
9. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
Riganti C; Castella B; Massaia M
Front Immunol; 2018; 9():1246. PubMed ID: 29937767
[TBL] [Abstract][Full Text] [Related]
10. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.
Vantourout P; Laing A; Woodward MJ; Zlatareva I; Apolonia L; Jones AW; Snijders AP; Malim MH; Hayday AC
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1039-1044. PubMed ID: 29339503
[TBL] [Abstract][Full Text] [Related]
11. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.
Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E
J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling between immunological synapse formation and functional outcome in human gamma delta T lymphocytes.
Favier B; Espinosa E; Tabiasco J; Dos Santos C; Bonneville M; Valitutti S; Fournié JJ
J Immunol; 2003 Nov; 171(10):5027-33. PubMed ID: 14607899
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of chiral phosphoantigens and their activity in gamma delta T cell stimulation.
Song Y; Zhang Y; Wang H; Raker AM; Sanders JM; Broderick E; Clark A; Morita CT; Oldfield E
Bioorg Med Chem Lett; 2004 Sep; 14(17):4471-7. PubMed ID: 15357974
[TBL] [Abstract][Full Text] [Related]
14. In vitro expansion of human γδ and CD56(+) T-cells by Aspergillus-antigen loaded fast dendritic cells in the presence of exogenous interleukin-12.
Ramadan G
Immunopharmacol Immunotoxicol; 2012 Apr; 34(2):309-16. PubMed ID: 21854188
[TBL] [Abstract][Full Text] [Related]
15. Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.
Boutin L; Scotet E
Front Immunol; 2018; 9():828. PubMed ID: 29731756
[TBL] [Abstract][Full Text] [Related]
16. γδ T cells: first line of defense and beyond.
Chien YH; Meyer C; Bonneville M
Annu Rev Immunol; 2014; 32():121-55. PubMed ID: 24387714
[TBL] [Abstract][Full Text] [Related]
17. Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease.
Hasan MS; Bergmeier LA; Petrushkin H; Fortune F
J Immunol Res; 2015; 2015():705831. PubMed ID: 26539557
[TBL] [Abstract][Full Text] [Related]
18. Vδ2
Davey MS; Willcox CR; Hunter S; Oo YH; Willcox BE
Front Immunol; 2018; 9():2106. PubMed ID: 30319605
[No Abstract] [Full Text] [Related]
19. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
[TBL] [Abstract][Full Text] [Related]
20. Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen.
Lafont V; Liautard J; Liautard JP; Favero J
J Immunol; 2001 Jun; 166(12):7190-9. PubMed ID: 11390467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
